Raychaudhuri, R., Khaki, A. R., Redman, M. W., Baker, K. K., Lin, A., Woo, B., Hannochka, A., Conrad, N., Vakar-Lopez, F., Yezefski, T., Schweizer, M. T., Montgomery, R. B., Yu, E. Y., Dash, A., Psutka, S. P., Lin, D. W., Schade, G. R., Gore, J. L., Wright, J. L., Grivas, P. (2025). Neoadjuvant pembrolizumab (pembro) and accelerated methotrexate, vinblastine, doxorubicin, cisplatin (aMVAC) in non-urothelial (non-UC) histologic subtype muscle invasive bladder cancer (MIBC): A phase 2 trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.5_suppl.769